efalizumab

navigate by keyword : antibody autoimmune biological biosimilar biotech biotechnology cd11a disease drug efalizumab immunoglobulin immunology infusion injection inn mab monoclonal nomenclature peptide protein psoriasis recombinant withdrawn

IgG1 monoclonal antibody (immunoglobulin). Play essential role i Royalty Free Stock Photo

Monoclonal antibody (Immunoglobulin G, IgG2a, mAb) molecule, chemical structure. Most current biotech drugs are monoclonal Royalty Free Stock Photo

IgG1 monoclonal antibody immunoglobulin. 3D rendering. Many biotech drugs are antibodies. Molecular surface model. Royalty Free Stock Photo

IgG1 monoclonal antibody (immunoglobulin), 3D rendering. Many biotech drugs are antibodies. Atoms are shown as color-coded spheres Royalty Free Stock Photo

IgG1 monoclonal antibody (immunoglobulin). 3D rendering. Many biotech drugs are antibodies. Cartoon representation with secondary Royalty Free Stock Photo

IgG1 monoclonal antibody (immunoglobulin). Many biotech drugs are antibodies. Cartoon representation with backbone gradient Royalty Free Stock Photo

Efalizumab monoclonal antibody drug. Targets CD11a but was withdrawn from the market due to safety issues. Generic name and

IgG2a monoclonal antibody (immunoglobulin). Many biotech drugs are antibodies. 3D rendering based on protein data bank entry 1igt Royalty Free Stock Photo

IgG1 monoclonal antibody (immunoglobulin). Many biotech drugs are antibodies. 3D rendering based on protein data bank entry 1igy Royalty Free Stock Photo

IgG2a monoclonal antibody immunoglobulin. Many biotech drugs are antibodies. Molecular surface model. Royalty Free Stock Photo

IgG2a monoclonal antibody (immunoglobulin), 3D rendering. Many biotech drugs are antibodies. Cartoon representation combined with Royalty Free Stock Photo

Efalizumab monoclonal antibody drug. Targets CD11a but was withdrawn from the market due to safety issues. Generic name and stylized antibody representation